Prediabetes management in the Middle East, Africa and Russia: Current status and call for action.


Journal

Diabetes & vascular disease research
ISSN: 1752-8984
Titre abrégé: Diab Vasc Dis Res
Pays: England
ID NLM: 101234011

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 5 1 2019
medline: 14 8 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

Most data on the burden of diabetes and prediabetes are from countries where local infrastructure can support reliable estimates of the burden of non-communicable diseases. Countries in the Middle East and Africa, together with Russia, have a total population of almost 2 billion, but have been relatively overlooked by authors in this field. We reviewed the prevalence and drivers of prediabetes and diabetes across this large region. A large, and variable, burden of dysglycaemia exists, especially in Middle Eastern and North African countries, associated with high levels of obesity and sedentariness, with a generally lower prevalence in most other parts of Africa. The design and size of studies are highly variable, and more research to quantify the scale of the problem is needed. Local barriers to care relating to issues concerned with gender, consanguinity, lack of understanding of diabetes, lack of understanding of obesity as a health issue, and limited resource at a national level for tracking and intervention for diabetes and other non-communicable diseases. Lifestyle interventions with proven local cost-effectiveness, enhanced access to pharmacologic intervention, and societal interventions to promote better diet and more activity will be an important element in strategies to combat these adverse trends.

Identifiants

pubmed: 30606039
doi: 10.1177/1479164118819665
doi:

Substances chimiques

Hypoglycemic Agents 0

Types de publication

Journal Article Review

Langues

eng

Pagination

213-226

Auteurs

Samir Helmy Assaad Khalil (SH)

1 Unit of Diabetology, Lipidology & Metabolism, Department of Internal Medicine, Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Sulaf Ibrahim Abdelaziz (SI)

2 Department of Internal Medicine and Endocrinology, Soba University Hospital, University of Khartoum, Khartoum, Sudan.

Affaf Al Shammary (A)

3 International Health Department, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.

Ali Al Zahrani (A)

4 Medicine and Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.

Ashraf Amir (A)

5 Department of Family Medicine, International Medical Center, Jeddah, Kingdom of Saudi Arabia.

Nabil Elkafrawy (N)

6 Egyptian National Committee of Diabetes, Department of Internal Medicine and Diabetology, Menoufia University, Al Menoufia, Egypt.

Ahmed Ak Hassoun (AA)

7 Dubai Diabetes Center, Dubai, UAE.

Ulrike Hostalek (U)

8 Merck KGaA, Darmstadt, Germany.

Adel Jahed (A)

9 Diabetes Education Advisory Committee, Gabric Diabetes Education Association, Tehran, Iran.
10 Tehran General Hospital, Tehran, Iran.

Nadim Jarrah (N)

11 Internal Medicine Department, The Specialty Hospital, Amman, Jordan.

Sanaa Mrabeti (S)

12 Merck Serono Middle East FZ-LLC, Dubai, UAE.

Imran Paruk (I)

13 University of KwaZulu-Natal, Durban, South Africa.

Alexey V Zilov (AV)

14 Department of Endocrinology, Sechenov's First Moscow Medical University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH